Functional food science and the cardiovascular system

British Journal of Nutrition

Volumn 80, Issue SUPPL. 1, 1998, Pages

  Hornstra, G ^a   Barth, C A ^b   Galli, C ^c   Mensink, R P ^a   Mutanen, M ^d   Riemersma, R A ^e   Roberfroid, M ^f   Salminen, K ^g   Vansant, G ^h   Verschuren, P M ⁱ  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^g VALIO LTD   (Finland)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LIPOPROTEIN; OMEGA 3 FATTY ACID; PYRIDOXINE; THROMBOXANE A2;

ARTERY THROMBOSIS; ATHEROSCLEROSIS; BLOOD CELL; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELLULAR IMMUNITY; DIABETES MELLITUS; DIET; FAT INTAKE; FIBRINOLYSIS; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; IMMUNE SYSTEM; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LEUKOCYTE; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; NUTRITION; NUTRITIONAL SCIENCE; OBESITY; REVIEW; SMOOTH MUSCLE FIBER; THROMBOCYTE FUNCTION; VASCULAR ENDOTHELIUM;

EID: 7344231091     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/bjn19980107     Document Type: Review

References (352)

1. Adler AJ & Holub BJ (1997) Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men. American Journal of Clinical Nutrition 65, 445-450.
2. Ågren JJ, Hanninen O, Julkunen A, Fogelholm L, Vidgren H, Schwab U, Pynnonen O & Unsitupa M (1996) Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels. European Journal of Clinical Nutrition 50, 765-771.
3. Almendingen K, Seljeflot I, Sandstad B & Pedersen JI (1996) Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on hemostatic variables in men. Arteriosclerosis, Thrombosis and Vascular Biology 16, 375-380.
4. Anderson JW, Johnstone BM & Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. New England Journal of Medicine 333, 276-282.
5. Antiplatelet Trialist's Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy. 1: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. British Medical Journal 308, 81-106.
6. Aro A, Jauhiainen M, Partanen R, Salminen I & Mutanen M (1997) Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins of healthy subjects. American Journal of Clinical Nutrition 65, 1419-1426.
7. Aronson DC, Onkenhout W, Raben AM, Oudenhoven LF, Brommer EJ & van Bockel JH (1994) Impaired homocysteine metabolism: a risk factor in young adults with atherosclerotic arterial occlusive disease of the leg. British Journal of Surgery 81, 1114-1118.
8. Asch S, Wingard DL & Barrett-Connor EL (1991) Are insulin and hypertension independently related? Annals of Epidemiology 1, 234-244.
9. Ascherio A, Hennekens C, Willett WC, Sachs F, Rosner B, Manson J, Witteman J & Stampfer MJ (1996a) Protective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension 27, 1065-1072.
10. Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer M & Willett WC (1996b) Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. British Medical Journal 313, 84-90.
11. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL & Willett WC (1995) Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. New England Journal of Medicine 332, 977-982.
12. Assman G & Schulte H (1992) Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary heart disease (The PROCAM Experience). American Journal of Cardiology 70, 733-737.
13. Austin MA (1992) Genetic epidemiology of low-density lipoprotein subclass phenotypes. Annals of Internal Medicine 24, 477-481.
14. Aviram M (1995) LDL-platelet interaction under oxidative stress induces macrophage foam cell formation. Thrombosis and Haemostasis 74, 560-564.
15. Banskota NK, Taub R, Zellner K, Olsen P & King GL (1989) Characterisation of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGD-I. Diabetes 38, 123-129.
16. Bath PMW & Butterworth RJ (1996) Platelet size: measurement, physiology and vascular disease. Blood Coagulation and Fibrinolysis 7, 157-161.
17. Bayon Y, Croset M, Daveloose D, Guerbette F, Chirouze V, Viret J, Kader JC & Lagarde M (1995) Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors. Journal of Lipid Research 36, 47-56.
18. Beilin LJ & Burke V (1995) Vegetarian diet components, protein and blood pressure: which nutrients are important? Journal of Clinical, Experimental and Pharmacological Physiology 22, 195-198.
19. Berrettini M, Parise P, Ricotta S, Iorio A, Peirone C & Nenci GG (1996) Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acids supplementation in patients with chronic atherosclerotic disease. Thrombosis and Haemostasis 75, 395-400.
20. Bienvenu T, Ankri A, Chadefaux B, Montalescot G & Kamoun P (1993) Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters. Thrombosis Research 70, 123-129.
21. Blaak EE & Saris WHM (1995) Health aspects of various digestible carbohydrates. Nutrition Research 15, 1547-1573.
22. Bladbjerg EM, Tholstrup T, Marckmann P, Sandström B & Jespersen J (1995) Dietary changes in fasting levels of factor VII coagulant activity (FVII:C) are accompanied by changes in factor VII protein and other vitamin K-dependent proteins, Thrombosis and Haemostasis 73, 239-242.
23. Blann AD, Jackson P, Bath PMW & Watts GF (1995) Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine 237, 557-561.
24. Blann A, Kumar P, Krupsinski J, Lip G & Beevers D (1996) Endothelial damage and adhesion molecules ICAM, VCAM, and E-selectin in acute stroke. Blood Coagulation and Fibrinolysis 7, 377.
25. Blann AD & McCollum CN (1994) Circulating endothelial cell/ leukocyte adhesion molecules in atherosclerosis. Thrombosis and Haemostasis 72, 151-154.
26. Bønaa K, Bjerve K, Straume B, Gram I & Thelle D (1990) Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. New England Journal of Medicine 322, 795-801.
27. Borkman M, Storlien LH, Pan DA, Jenkins AD, Chisholm DJ & Campbell LV (1993) The relation between insulin sensitivity and the fatty-acid composition of skeletal muscle phospholipids. New England Journal of Medicine 328, 238-244.
28. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PW, Schaefer EJ & Castelli WP (1996) Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. Journal of the American Medical Association 276, 544-548.
29. Boulanger CM, Tanner FC, Hahn A, Wa A, Werner A & Lüscher TF (1992) Oxidised low-density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circulation Research 70, 1191-1197.
30. Boushey CJ, Beresford SA, Omenn GS & Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes [see comments]. Journal of the American Medical Association 274, 1049-1057.
31. Bronsgeest-Schoute DC, Hautvast JG & Hermus RJ (1979) Dependence of the effects of dietary cholesterol and experimental conditions on serum lipids in man. I. Effects of dietary cholesterol in a linoleic acid-rich diet. American Journal of Clinical Nutrition 32, 2183-2187.
32. Brown AS & Martin JF (1994) The megakaryocyte platelet system and vascular disease. European Journal of Clinical Investigation 24, Suppl. 1, 9-15.
33. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM & Deadman NM (1989) Effect of changes in fat, fish and fibre intakes on death and myocardial infarction: diet and reinfarction trial (DART). Lancet ii, 757-761.
34. Cairns JA, Gill J, Morton B, Roberts R, Gent M, Hirsch J, Holder D, Finnie K, Marquis JF, Naqvi S & Cohen E (1996) Fish oils and low molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR study. Circulation 94, 1553-1560.
35. Calder PC (1996) Immunomodulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Proceedings of the Nutrition Society 55, 737-774.
36. Calder PC & Newsholme EA (1992) Polyunsaturated fatty acids suppress human peripheral blood lymphocyte proliferation and interleukin-2 production. Clinical Science 82, 695-700.
37. Cambien F (1987) Is insulin the key factor to explain the associations between body mass, blood pressure and glucose? Diabète et Métabolisme 13, 973-978.
38. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L & Ricard S (1992) Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 359, 641-644.
39. Castelli WP, Anderson K, Wilson PW & Levy D (1992) Lipids and risk of coronary heart disease. The Framingham Study. Annals of Epidemiology 2, 23-28.
40. Cater NB, Heller HJ & Denke MA (1997) Comparison of the effects of medium chain triacylglycerols, palm oil, and high oleic acid sunflower oil on plasma triacylglycerol fatty acids and lipid and lipoprotein concentrations in humans. American Journal of Clinical Nutrition 65, 41-45.
41. Chalmers TC, Matta RJ, Smith HR Jr & Kunzler AM (1977) Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. New England Journal of Medicine 297, 1091-1096.
42. Chan JK, Bruce VM & McDonald BE (1991) Dietary α-linolenic acid is as effective as oleic acid and linoleic acid in lowering blood cholesterol in normolipidemic men. American Journal of Clinical Nutrition 53, 1230-1234.
43. Charnock JS (1994) Lipids and cardiac arrhythmias. Progress in Lipid Research 33, 355-385.
44. Chasan-Taber L, Selhub J, Rosenberg IH, Malinow MR, Terry P, Tishler PV, Willett W, Hennekens CH & Stampfer MJ (1996) A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. Journal of the American College of Nutrition 15, 136-143.
45. Choudhury N, Tan L & Truswell AS (1995) Comparison of palmolein and olive oil: effects on plasma lipids and vitamin E in young adults. American Journal of Clinical Nutrition 61, 1043-1051.
46. Choudhury SR, Ueshima H, Kita Y, Kobayashi KM, Okayama A, Yamakawa M, Hirao Y, Ishikawa M & Miyoshi Y (1994) Alcohol intake and serum lipids in a Japanese population. International Journal of Epidemiology 23, 940-947.
47. Clarke R, Frost C, Collins R, Appleby P & Peto R (1997) Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. British Medical Journal 314, 112-117.
48. Clarke R, Naughten E, Cahalane S, Sullivan KO, Mathias P, McCall T & Graham I (1992) The role of free radicals as mediators of endothelial cell injury in hyperhomocysteinaemia. Irish Journal of Medical Science 161, 561-564.
49. Collie-Duguid ESR & Wahle KWJ (1996) Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochemical and Biophysical Research Communications 220, 969-974.
50. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO & Hennekens CH (1990) Blood pressure, stroke, and coronary heart disease. Part 2. Lancet 335, 827-838.
51. Colman E, Katzel LI, Rogus E, Coon P, Muller D & Goldberg AP (1995) Weight loss reduces abdominal fat and improves insulin action in middle-aged and older men with impaired glucose tolerance. Metabolism 44, 1502-1508.
52. Curb JD & Reed DM (1985) Fish consumption and mortality from coronary heart disease. New England Journal of Medicine 313, 821-822.
53. Curmi PA, Juan L & Tedgui A (1990) Effect of transmural pressure on low density lipoprotein and albumin transport and distribution across the intact arterial wall. Circulation Research 66, 1692-1702.
54. Dalery K, Lussier CS, Selhub J, Davignon J, Latour Y & Genest JJ (1995) Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and Mate. American Journal of Cardiology 75, 1107-1111.
55. Davidson MH, Maki KC, Kalkowski J, Schaefer EJ, Torri SA & Drennan KB (1997) Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia. A randomized, double-blind, placebo-controlled trial. Journal of the American College of Nutrition 16, 236-243.
56. Davies MJ (1997) The composition of coronary artery plaques. New England Journal of Medicine 336, 1312-1314.
57. Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P, Walsh MK, Morris D & Shekelle RB (1997) Fish consumption and the 30-year risk of fatal myocardial infarction. New England Journal of Medicine 336, 1046-1053.
58. De Caterina R, Cybulski MI, Clinton SK, Gimbrone MA Jr & Libby P (1994) The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arteriosclerosis and Thrombosis 14, 1829-1836.
59. De Caterina R, Cybulski MA, Clinton SK, Gimbrone MA & Libby P (1995a) Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostaglandins, Leukotrienes and Essential Fatty Acids 52, 191-195.
60. De Caterina R, Tanaka H, Nakagawa T, Hauptman PJ & Libby P (1995b) The direct effect of injectable cyclosporine and its vehicle, cremophor, on endothelial vascular cell adhesion molecule-1 expression. Transplantation 60, 270-275.
61. De Deckere EAM & ten Hoor F (1979) Effects of dietary fats on the coronary flow rate and the left ventricular function of the isolated rat heart. Nutrition and Metabolism 23, 88-97.
62. DeForge LE, Fantone JC, Kenney JS & Remick DG (1992) Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. Journal of Clinical Investigation 90, 2123-2129.
63. DeFronzo RA (1981) The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia 21, 165-171.
64. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin J-L, Monjaud I, Guidollet J, Touboul P & Delaye J (1994) Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343, 1454-1459.
65. Desprès JP & Marette A (1994) Relation of components of insulin resistance syndrome to coronary disease risk. Current Opinion in Lipidology 5, 274-289.
66. Diplock AT, Charleux J-L, Crozier-Willi G, Kok FJ, Rice-Evans C, Roberfroid M, Stahl W & Viña-Ribes J (1998) Functional food science and defence against reactive oxygen species. British Journal of Nutrition 80, Suppl. 1, S77-S112.
67. Dolecek TA & Grandits G (1991) Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Review of Nutrition and Dietetics 66, 205-216.
68. Dreon DM, Fernstrom HA, Miller B & Krauss RM (1995) Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. Arteriosclerosis, Thrombosis and Vascular Biology 15, 105-111.
69. Dudman NP, Guo XW, Gordon RB, Dawson PA & Wilcken DE (1996) Human homocysteine catabolism: three major pathways and their relevance to development of arterial occlusive disease. Journal of Nutrition 126, 1295S-1300S.
70. Dudman NP, Hicks C, Wang J & Wilcken DE (1991) Human endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis 91, 77-83.
71. Elliott TG & Viberti G (1993) Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal. Baillière's Clinical Endocrinology and Metabolism 7, 1079-1103.
72. Ellis JM & McCully KS (1995) Prevention of myocardial infarction by vitamin B6. Research Communications in Molecular Pathology and Pharmacology 89, 208-220.
73. Elwood PC, Beswich AD, Sharp DS, Yarnell JW, Rogers S & Renaud S (1990) Whole blood impedance platelet aggregometry and ischaemic heart disease. The Caerphilly Collaborative Heart Disease Study. Arteriosclerosis 10, 1032-1036.
74. Elwood PC, Renaud S, Sharp DS, Beswick AD, O'Brien JR & Yarnell JW (1991) Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation 83, 38-44.
75. Endres S, De Caterina R, Schmidt EB & Kristensen SD (1995a) N-3 polyunsaturated fatty acids: update 1995. European Journal of Clinical Investigation 25, 629-638.
76. Endres S, Eisenhut T & Sinha B (1995b) N-3 polyunsaturated fatty acids in the regulation of human cytokine synthesis. Biochemical Society Transactions 23, 277-281.
77. Endres S, Meydani SN, Ghorbani R, Schindler R & Dinarello CA (1993) Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation. Journal of Leukocyte Biology 54, 599-603.
78. EPIC Investigators (1994) Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. New England Journal of Medicine 330, 956-961.
79. Eritsland J, Seljeflot I, Abdelnoor M & Arnesen H (1994) Long-term influence of omega-3 fatty acids on fibrinolysis, fibrinogen, and serum lipids. Fibrinolysis 8, 120-125.
80. Eritsland J, Arnesen H, Seljeflot I & Kierulf P (1995) Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagulation and Fibrinolysis 6, 17-22.
81. Faruqi R, de la Motte C & Di Corleto P (1994) α-Tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. Journal of Clinical Investigation 94, 592-600.
82. Ferrannini E, Haffner SL, Mitchell BD & Sterm MP (1991) Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 3, 416-422.
83. Feskens EJM, Loeber JG & Kromhout D (1994) Diet and physical activity as determinants of hyperinsulinemia: the Zutphen Elderly Study. American Journal of Epidemiology 140, 350-360.
84. Fibrinolytic Trialists' Collaborative Group (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity events from the randomized trials of more than 1000 patients. Lancet 343, 311-322.
85. Fischer S, Weber PC & Dyerberg J (1986) The prostacyclin/ thromboxane balance is favourably shifted in Greenland Eskimos. Prostaglandins 32, 235-240.
86. Fontbonne A, Charles MS & Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE & Eschwege E (1991) Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study 15-year follow-up. Diabetologia 34, 356-361.
87. Frayn KN (1993) Insulin resistance and lipid metabolism. Current Opinion in Lipidology 4, 197-204.
88. Freese R & Mutanen M (1997) Alpha-linolenic acid and marine n-3 fatty acids only slightly differ in their effects on hemostatic factors in healthy subjects. American Journal of Clinical Nutrition 66, 591-598.
89. Frenette PS & Wagner DD (1996) Adhesion molecules - Part II: Blood vessels and blood cells. New England Journal of Medicine 335, 43-45.
90. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, Mäenpää H, Mälkönen M, Mänttäri M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjöblom T & Nikkilä EA (1987) Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. New England Journal of Medicine 317, 1237-1245.
91. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heyer M, Kluijtmans LA, van den Heuvel LP & Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase (letter). Nature Genetics 10, 111-113.
92. Frøyland L, Madsen L, Vaagenes H, Totland GK, Auwerx J, Kryvi H, Staels B & Berge RK (1997) Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism. Journal of Lipid Research 38, 1851-1858.
93. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA & Rodgers GM (1993) Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arteriosclerosis and Thrombosis 13, 1327-1333.
94. Fujikawa, M, Yamashita N, Yamazaki K, Sugiyama E, Suzuki H & Hamazaki T (1992) Eicosapentaenoic acid inhibits antigen-presenting cell function of murine splenocytes. Immunology 75, 330-335.
95. Fulton M, Thomson M, Elton RA, Brown S, Wood DA & Oliver MF (1988) Cigarette smoking, social class and nutrient intake. Relevance to coronary heart disease. European Journal of Clinical Nutrition 42, 797-803.
96. Fuster V, Badimon L, Badimon JJ & Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes. New England Journal of Medicine 326, 242-250.
97. Fuster V, Stein B, Ambrose JA, Badimon JJ & Chesebro JH (1990) Atherosclerotic plaque rupture and thrombosis: evolving concepts. Circulation 82, Suppl. II, 47-59.
98. Fyfe AI, Qiao JH & Lusis AJ (1994) Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. Journal of Clinical Investigation 94, 2516-2520.
99. Gapinski JP, van Ruiswyk JV, Heudebert GR & Schectman GS (1993) Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis. Archives of Internal Medicine 153, 1595-1601.
100. Geng Y-J & Hansson GK (1992) Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. Journal of Clinical Investigation 89, 1322-1330.
101. Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M & Ludin E (1993) Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. American Journal of Clinical Nutrition 57, Suppl., 787-797.
102. Ghaddar HM, Cortes J, Salomaa V, Kark JD, Davis CE, Folsom AR, Heiss G, Stinson V & Wu KK (1995). Correlation of specific platelet activation markers with carotid arterial wall thickness. Thrombosis and Haemostasis 74, 984-948.
103. Glore SR, Van Treeck D, Knehans AW & Guild M (1994) Soluble fiber and serum lipids: a literature review. Journal of the American Dietetic Association 94, 425-436.
104. Goldberg DM (1996) More on antioxidant activity of resveratrol in red wine (letter). Clinical Chemistry 42, 113-114.
105. Gordon D, Reidy MA, Benditt EP & Schwartz SM (1990) Cell proliferation in human coronary arteries. Proceedings of the National Academy of Sciences USA 87, 4600-4604.
106. Gorgels WJMJ, van der Graaf Y, Hjemdahl P, Kortlandt W, Collette HJA, Erkelens DW & Banga J-D (1995) Urinary excretions of high molecular weight β-thromboglobulin and albumin are independently associated with coronary heart disease in women, a nested case-control study of middle-aged women in the diagnostisch onderzoek mammacarcinoom (DOM) cohort, Utrecht, Netherlands. American Journal of Epidemiology 142, 1157-1164.
107. Goyette P, Frosst P, Rosenblatt DS & Rozen R (1995) Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. American Journal of Human Genetics 56, 1052-1059.
108. Grainger DJ & Metcalfe JC (1995) Transforming growth factor-beta: the key to understanding lipoprotein(a)? Current Opinion in Lipidology 6, 81-85.
109. Grande F, Anderson JT & Keys A (1970) Comparison of effects of palmitic and stearic acids in the diet on serum cholesterol in man. American Journal of Clinical Nutrition 23, 1184-1193.
110. Grimsgaard S, Bønaa KH, Hansen JB & Nordøy A (1997) Highly purified eicosapentaenoic and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. American Journal of Clinical Nutrition 66, 649-659.
111. Groppelli A, Giorgi DMA, Omboni S, Parati G & Mancia G (1992) Persistent blood pressure increase induced by heavy smoking. Journal of Hypertension 10, 495-499.
112. Guttormsen AB, Schneede J, Ueland PM & Refsum H (1996) Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency. American Journal of Clinical Nutrition 63, 194-202.
113. Hackman A, Abe Y, Insull W Jr, Pownall H, Smith L, Dunn K, Gotto AM Jr & Ballantyne CM (1996) Levels of soluble cell-adhesion molecules in patients with dyslipidemia. Circulation 93, 1334-1338.
114. Hajjar KA (1993) Homocysteine induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. Journal of Clinical Investigation 91, 2873-2879.
115. Hamano H, Nanba A, Nagayama M, Takizawa S & Shinohara Y (1996) [An adult case of homocystinuria due to methylene-tetrahydrofolate-reductase deficiency-treatment with folic acid and the course of coagulation-fibrinolysis parameters.] Rinsho-Shinkeigaku 36, 330-335.
116. Hamazaki T, Fischer S, Urakaza M, Sawazaki S, Yano S & Kuwamori T (1989) Urinary excretion of PGI2/3-M and recent n-6/3 fatty acid intake. Prostaglandins 37, 417-424.
117. Hamsten A (1995) Hemostatic function and coronary artery disease. New England Journal of Medicine 332, 677-678.
118. Hansen JB, Huseby NE, Sandset PM, Svensson B, Lyngmo V & Nordøy A (1994) Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma. Arteriosclerosis and Thrombosis 14, 223-229.
119. Hansson GK, Holm J, Holm S, Fotev Z, Hedric HJ & Fingerle J (1991) T-lymphocytes inhibit the vascular response to injury. Proceedings of the National Academy of Sciences USA 88, 10530-10534.
120. Harker LA, Slichter SJ, Scott CR & Ross R (1974) Homocysteinemia, vascular injury and arterial thrombosis. New England Journal of Medicine 291, 537-543.
121. Harpel PC & Borth W (1992) Identification of mechanisms that may modulate the role of lipoprotein(a) in thrombosis and atherogenesis. Annals of Epidemiology 2, 413-417.
122. Harpel PC, Zhang X & Borth W (1996) Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. Journal of Nutrition 126, 1285S-1289S.
123. Harris WS (1997) n-3 fatty acids and serum lipoproteins: human studies. American Journal of Clinical Nutrition 65, 1645S-1654S.
124. Harris WS & Muzio F (1993) Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates. American Journal of Clinical Nutrition 58, 68-74.
125. Hayes KC & Khosla P (1992) Dietary fatty acid thresholds and cholesterolemia. FASEB Journal 6, 2600-2607.
126. Hayes KC, Khosla P, Pronczuk A & Lindsey S (1992) Re-examination of the dietary fatty acid-plasma cholesterol issue: is palmitic acid (16:0) neutral? In Cholesterol and Coronary Heart Disease - The Great Debate, pp. 189-206 [P Gold, S Grover and DAK Roncari, editors]. Carnforth: Parthenon Publishing Group.
127. Hayford JT, Danney MM, Wiebe MCD, Roberts S & Thompson RG (1979) Triglyceride integrated concentrations: effect of variation of source and amount of dietary carbohydrate. American Journal of Clinical Nutrition 32, 1670-1678.
128. Healy B (1990) Endothelial cell dysfunction: an emerging endocrinopathy linked to coronary artery disease. Journal of the American College of Cardiology 16, 357-358.
129. Hegsted DM, McGandy RB, Myers ML & Stare FJ (1965) Quantitative effects of dietary fat on serum cholesterol in man. American Journal of Clinical Nutrition 17, 281-295.
130. Heijnen ML, van Amelsvoort JM, Deurenberg P & Beynen AC (1996) Neither raw nor retrograded resistant starch lowers fasting serum cholesterol concentrations in healthy normolipidemic subjects. American Journal of Clinical Nutrition 64, 312-318.
131. Hellsten G, Boman K, Saarem K, Hallmans G & Nilsson T (1993) Effects on fibrinolytic activity of corn oil and a fish oil preparation enriched with omega-3 polyunsaturated fatty acids in a long-term study. Current Medical Research Opinion 13, 133-139.
132. Henning B, Toborek M, Joshi-Barve S, Barger SW, Barve S, Mattson MP & McClain CJ (1996) Linoleic acid activates nuclear transcription factor-κB (NF-κB) and induces NF-κB-dependent transcription in cultured endothelial cells. American Journal of Clinical Nutrition 63, 322-328.
133. Herzlich BC, Lichstein E, Schulhoff N, Weinstock M, Pagala M, Ravindran K, Namba T, Nieto FJ, Stabler SP & Allen RH (1996) Relationship among homocyst(e)ine, vitamin B-12 and cardiac disease in the elderly: association between vitamin B-12 deficiency and decreased left ventricular ejection fraction. Journal of Nutrition 126, 1249S-1253S.
134. 111indium-labeled platelets in patients with homocystinuria. New England Journal of Medicine 307, 781-786.
135. Himsworth HP (1936) Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. Lancet i, 127-130.
136. Hokanson JE & Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. Journal of Cardiovascular Risk 3, 213-219.
137. Hopkins PN (1992) Effects of dietary cholesterol on serum cholesterol: a meta-analysis and review. American Journal of Clinical Nutrition 55, 1060-1070.
138. Hornstra G (1989) The significance of fish and fish-oil enriched food for prevention and therapy of ischaemic cardiovascular disease. In The Role of Fats in Human Nutrition II, pp. 151-235 [AJ Vergroesen and MA Crawford, editors]. New York, NY: Academic Press.
139. Hornstra G (1992) The effect of the n-3 fatty acids on blood coagulation. In Fish Oil and Vascular Disease, pp. 65-72 [R DeCaterina, SD Kristensen and EB Schmidt, editors]. Berlin: Springer-Verlag.
140. Hornstra G, Hennissen AAHM & Wierts JW (1993) The effect of dietary fatty acids on platelet function and arterial thrombosis. In Essential Fatty Acids and Eicosanoids, pp. 287-289 [A Sinclair and R Gibson, editors]. Champaign, IL: American Oil Chemist's Society.
141. Hornstra G, van Houwelingen AC, Kivits GAA, Fischer S & Uedelhoven W (1990) Influence of dietary fish on eicosanoid metabolism in man. Prostaglandins 40, 311-329.
142. Horrobin DF (1993) Fatty acid metabolism in health and disease: the role of Δ6-desaturase. American Journal of Clinical Nutrition 57, Suppl., 732S-737S.
143. Hultberg B, Andersson A & Isaksson A (1995) Metabolism of homocysteine, its relation to the other cellular thiols and its mechanism of cell damage in a cell culture line (human histiocytic cell line U-937). Biochimica et Biophysica Acta 1269, 6-12.
144. Hunter DJ, Kazda T, Chokalingam A & Fodor JG (1988) Fish consumption and cardiovascular mortality in Canada: an inter-regional comparison. American Journal of Preventive Medicine 4, 5-10.
145. Jacobsen DW, Gatautis VJ, Green R, Robinson K, Savon SR, Secic M, Ji J, Otto JM & Taylor LJ (1994) Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects [see comments]. Clinical Chemistry 40, 873-881.
146. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J & Rozen R (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 7-9.
147. Jandacek RJ, Ramirez MM & Crouse JR (1990) Effects of partial replacement of dietary fat by olestra on dietary cholesterol absorption in man. Metabolism 39, 848-852.
148. Jeppesen J, Chen YDI, Zhou MY, Wang T & Reaven GM (1995) Effect of variations in oral fat and carbohydrate load on post-prandial lipemia. American Journal of Clinical Nutrition 62, 1201-1205.
149. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR & Lalouel J-M (1992) Absence of linkage between angiotensin converting enzyme locus and human essential hypertension. Nature Genetics 1, 72-75.
150. Jonasson L, Holm J, Skalli O, Bondjers G & Hansson GK (1986) Regional accumulation of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6, 131-138.
151. Jones BG, Rose FA & Tudball N (1994) Lipid peroxidation and homocysteine induced toxicity. Atherosclerosis 105, 165-170.
152. Kaminski WE, Jendraschak E, Kiefl R & von Shacky C (1993) Dietary ω-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells. Blood 81, 1871-1879.
153. Kardinaal AFM, Aro A, Kark JD, Riemersma RA, van't Veer P, Gomez-Aracena J, Kohlmeier L, Ringstad J, Martin BC, Mazaev VP, Delgado-Rodriguez M, Thamm M, Huttunen JK, Martin-Moreno JM & Kok FJ (1995) Association between
154. Karpe F, Steiner G, Uffelman K, Olivecrona T & Hamsten A (1994) Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106, 83-97.
155. Katan MB, Beynen AC, de Vries JHM & Nobels A (1986) Existence of consistent hypo- and hyperresponders to dietary cholesterol in man. American Journal of Epidemiology 123, 221-234.
156. Katan MB, Zock PL & Mensink RP (1995) Trans fatty acids and their effects on lipoproteins in humans. Annual Reviews of Nutrition 15, 473-493.
157. Kelley DS, Nelson GJ, Serrato CM, Schmidt PC & Branch LB (1988) Effects of type of dietary fat on indices of immune status of rabbits. Journal of Nutrition 118, 1376-1384.
158. Kelly JP & Parker CW (1979) Effect of arachidonic acid and other unsaturated fatty acids on mitogenesis in human lymphocytes. Journal of Immunology 122, 1556-1562.
159. Kesaniemi YA & Grundy SM (1982) Lack of effect of tocopherol on plasma lipids and lipoproteins in man. American Journal of Clinical Nutrition 36, 224-228.
160. Keys A, Anderson JT & Grande F (1965a) Serum cholesterol response to changes in the diet II. The effect of cholesterol in the diet. Metabolism 14, 759-765.
161. Keys A, Anderson JT & Grande F (1965b) Serum cholesterol response to changes in the diet IV. Particular saturated fatty acids in the diet. Metabolism 14, 776-786.
162. Khan WA, Blobe GC & Hannun YA (1995) Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. Cellular Signalling 7, 171-184.
163. Knapp HR, Rielly IAG, Allessandrini P & FitzGerald GA (1986) In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. New England Journal of Medicine 314, 937-942.
164. Kokame K, Kato H & Miyata T (1996) Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes. Journal of Biological Chemistry 271, 29659-29665.
165. Kritchevsky D & Tepper SA (1977) Cholesterol vehicle in experimental atherosclerosis. Part 15. Randomized butter and randomized lard. Atherosclerosis 27, 339-345.
166. Kritchevsky D, Tepper SA, Vesselinovitch D & Wissler RW (1973) Cholesterol vehicle in experimental atherosclerosis. Randomized peanut oil. Atherosclerosis 17, 225-243.
167. Kromhout D (1985) Fish consumption and mortality from coronary heart disease. New England Journal of Medicine 313, 824.
168. Kromhout D, Bosschieter EB & de Lezenne Coulander C (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. New England Journal of Medicine 312, 1205-1209.
169. Landsberg L & Krieger DR (1989) Obesity, metabolism, and the sympathetic nervous system. American Journal of Hypertension 2, 125S-132S.
170. Lapidus L, Andersson H, Bengtsson C & Bosaeus I (1986) Dietary habits in relation to incidence of cardiovascular disease and death in women: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden. American Journal of Clinical Nutrition 44, 444-448.
171. Laws A & Reaven GM (1993) Insulin resistance and the risk factors for coronary heart disease. Baillière's Clinical Endocrinology and Metabolism 7, 1079-1103.
172. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR & Heistad DD (1996) Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia [see comments]. Journal of Clinical Investigation 98, 24-29.
173. Leprán I, Nemecz GY, Koltai M & Szekeres L (1981) Effect of linoleic acid rich diet on the acute phase of coronary occlusion in conscious rats: influence of indomethacin and aspirin. Journal of Cardiovascular Pharmacology 3, 847-853.
174. Lewis GF, O'Meara NM, Soltys PA, Blackman JD, Iverius PH, Pugh WL, Getz GS & Polonsky KS (1990) Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. Journal of Clinical Endocrinology and Metabolism 71, 1041-1050.
175. Lillioja S, Young AA, Culter CA, Ivy JL, Abbott WG, Zawadzki JK, Yki-Jarvinen H, Christin L, Secomb TW & Bogardus C (1987) Skeletal muscle capillary density and fibre type are possible determinants of in vivo insulin resistance in man. Journal of Clinical Investigation 80, 415-424.
176. Lindgren A, Lindoff C, Norrving B, Astedt B & Johansson BB (1996) Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke 27, 1066-1071.
177. Ling WH & Jones PJ (1995) Dietary phytosterols: a review of metabolism, benefits and side effects. Life Science 5, 195-206.
178. Lissner L, Bengtsson C, Lapidus L, Kristjansson K & Wedel H (1992) Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension 20, 797-801.
179. Lodish H, Baltimore D, Berk A, Zipurski SL, Matsudavia M & Darnell J (1995) Chapter 27. Immunity. In Molecular Cell Biology, 3rd ed. New York, NY: Scientific American Books.
180. Loeliger EA (1984) Oral anticoagulation in patients surviving myocardial infarction. A new approach to old data. European Journal of Clinical Pharmacology 26, 137-139.
181. Lopez-Miranda J, Ordovas JM, Espino A, Marin C, Salas J, Lopez-Segura F, Jimenez-Pereperez J & Perez-Jimenez F (1994) Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat. Lancet 343, 1246-1249.
182. Lopez-Segura F, Velasco F, Lopez-Miranda J, Castro P, Lopez-Pedrera R, Blanco A, Jimenez-Pereperez J, Torres A, Trujillo J, Ordovas JM & Perez-Jimenez F (1996) Monounsaturated fatty acid-enriched diet decreases plasma plasminogen activator inhibitor type 1. Arteriosclerosis, Thrombosis and Vascular Biology 16, 82-88.
183. Loscalzo J, Pasche B, Ouimet H & Freedman JE (1995) Platelets and plasminogen activation. Thrombosis and Haemostasis 74, 291-293.
184. Lucas CP, Estigarribia JA, Darga LL & Reaven GM (1985) Insulin and blood pressure in obesity. Hypertension 7, 702-706.
185. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC & Rozen R (1996) Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 94, 2410-2416.
186. McCully KS (1993) Chemical pathology of homocysteine. I. Atherogenesis. Annals of Clinical and Laboratory Sciences 23, 477-493.
187. McGill HC Jr (1984) Persistent problems in the pathogenesis of atherosclerosis: atherogenesis and inflammation. Arteriosclerosis 4, 443-451.
188. McLennan PL (1993) Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. American Journal of Clinical Nutrition 57, 207-212.
189. McLennan PL, Abeywardena MY & Charnock JS (1985) Influence of dietary lipid on arrhythmias and infarction after coronary ligation in rats. Canadian Journal of Physiology and Pharmacology 63, 1411-1417.
190. McLennan PL, Abeywardena MY & Charnock JS (1989) The influence of age and dietary fat in an animal model of sudden cardiac death. Australian and New Zealand Journal of Medicine 19, 1-5.
191. McLennan PL, Abeywardena MY & Charnock JS (1990) Reversal of the arrhythmogenic effects of long-term saturated fatty acid intake by dietary n-3 and n-6 polyunsaturated fatty acids. American Journal of Clinical Nutrition 51, 53-58.
192. McLennan P & Dallimore JA (1995) Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats. Journal of Nutrition 125, 1003-1009.
193. MacLeod DC, Heagerty AM, Bund SJ, Lawal TS & Riemersma RA (1994) Effect of dietary polyunsaturated fatty acids on contraction and relaxation of rat femoral resistance arteries. Journal of Cardiovascular Pharmacology 23, 92-98.
194. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A & Stamler J (1990) Blood pressure, stroke, and coronary heart disease. Part 1. Lancet 335, 765-774.
195. Malinow MR (1996) Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases. Journal of Nutrition 126, 1238S-1243S.
196. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen OP & Frick MH (1992) Joint effects of serum triglyceride and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 85, 37-45.
197. Marckmann P, Sandström B & Jespersen J (1993) Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arteriosclerosis and Thrombosis 13, 505-511.
198. Martin JF, Bath PM & Burr ML (1991) Influence of platelet size on outcome after myocardial infarction. Lancet 338, 1409-1411.
199. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Aleander RW & Medford RM (1993) Vascular adhesion molecule-1 (VCAM) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. Journal of Clinical Investigation 92, 1866-1874.
200. Mata P, Ordovas JM, Lopez-Miranda J, Lichtenstein AH, Clevidence B, Judd JT & Schaefer EJ (1994) ApoA-IV phenotype affects diet-induced plasma LDL cholesterol lowering. Arteriosclerosis and Thrombosis 14, 884-891.
201. Mayer EJ, Newman B, Quesenberry CP & Selby JV (1993) Usual dietary fat intake and insulin concentrations in healthy women twins. Diabetes Care 16, 1459-1469.
202. Meade TW, Brozovic M, Chakrabarti RR, Hannes AP, Imeson JD, Mellows S, Miller GJ, North WRS, Stirling Y & Thompson SG (1986) Haemostatic function and ischaemic heart disease: principal results of the Northwick Park heart study. Lancet ii, 533-537.
203. Meade TW, Ruddock V, Stirling Y, Chakrabarti R & Miller GI (1993) Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 342, 1076-1079.
204. Mellies MJ, Jandacek RJ, Taulbee JD, Tewkesbury MB, Lamkin G, Baehler L, King P, Boggs D, Goldman S, Gouge A, Tsang R & Glueck CJ (1983) A double-blind, placebo controlled study of sucrose polyester in hypercholesterolemic outpatients. American Journal of Clinical Nutrition 37, 339-346.
205. Mennen LI, Schouten EG, Grobbee DE & Kluft C (1996) Coagulation factor VII, dietary fat and blood lipids: a review. Thrombosis and Haemostasis 76, 492-499.
206. Mensink RP & Katan MB (1992) Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arteriosclerosis and Thrombosis 12, 911-919.
207. Meydani SN, Lichtenstein AH, Cornwall S, Meydani M, Goldin BR, Rasmussen H, Dinarello CA & Schaefer EJ (1993) Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived n-3 fatty acid enrichment. Journal of Clinical Investigation 92, 105-113.
208. Middleton E & Kandaswami C (1992) Commentary. Effects of flavonoids on immune and inflammatory cell functions. Biochimica et Biophysica Acta 43, 1167-1179.
209. Miettinen TA (1991) Impact of apoE phenotype on the regulation of cholesterol metabolism. Annals of Medicine 23, 181-186.
210. Miettinen TA, Naukkarinen V, Huttunen JK, Mattila S & Kumlin T (1982) Fatty-acid composition of serum lipids predicts myocardial infarction. British Medical Journal 285, 993-996.
211. Miettinen TA, Puska P, Gylling H, Vanhanen H & Vartiainen E (1995) Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. New England Journal of Medicine 333, 1308-1312.
212. Miller GJ (1995) Lipoproteins and thrombosis: effects of lipid lowering. Current Opinion in Lipidology 6, 38-42.
213. Miller GJ, Bauer KA, Barzegar S, Cooper JA & Rosenberg RD (1996) Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thrombosis and Haemostasis 75, 767-771.
214. Mitropoulos KA (1994) Lipoprotein metabolism and thrombosis. Current Opinion in Lipidology 5, 227-235.
215. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A & Fuchs Z (1985) Hyperinsulinaemia: a link between hypertension, obesity and glucose intolerance. Journal of Clinical Investigation 75, 809-817.
216. Mohan P, Sys SU & Brutsaert DL (1994) Nitric oxide donors induce a positive inotropic effect mediated by cGMP in isolated cardiac muscle without endothelium. European Heart Journal 15, Suppl., 144.
217. Morris MC, Manson JE, Rosner B, Buring JE, Willett WC & Hennekens CH (1992) A prospective study of fish consumption on cardiovascular disease. Circulation 86, Suppl. 1, 463.
218. Morris MC, Sacks F & Rosner B (1993) Does fish oil lower blood pressure? A meta analysis of controlled trials. Circulation 88, 525-533.
219. Mutanen M (1997) Cis-unsaturated fatty acids and platelet function. Prostaglandins Leukotrienes and Essential Fatty Acids 57, 403-410.
220. Mutanen M & Aro A (1997) Coagulation and fibrinolysis factors in healthy subjects consuming high stearic or trans fatty acids. Thrombosis and Haemostasis 77, 99-104.
221. Murohara T, Scalia R & Lefer AM (1996) Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circulation Research 78, 780-789.
222. Nestel PJ, Noakes M, Belling GB, McArthur R & Clifton PM (1995) Effect on plasma lipids of interesterifying a mix of edible oils. American Journal of Clinical Nutrition 62, 950-955.
223. Ng TKW, Hayes KC, DeWitt GF, Jegathesan M, Satgunasingam N, Ong AS & Tan D (1992) Dietary palmitic acid and oleic acids exert similar effects on serum cholesterol and lipoprotein profiles in normocholesterolemic men and women. Journal of the American College of Nutrition 11, 383-390.
224. Nilsson TK, Sundell IB, Hellsten G & Hallmans G (1990) Reduced plasminogen activator inhibitor in high consumers of fruits, vegetables and root vegetables. Journal of Internal Medicine 227, 267-271.
225. Nishinaga M, Ozawa T & Shimada K (1993) Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. Journal of Clinical Investigation 92, 1381-1386.
226. Novell SE, Ahlbom A, Feychting M & Pedersen NL (1986) Fish consumption and mortality from coronary heart disease. British Medical Journal 293, 426.
227. Ochi H, Kume N, Nishi E & Kita T (1995) Elevated levels of cAMP inhibit protein kinase C-independent mechanisms of endothelial platelet-derived growth factor-B chain and intercellular adhesion molecule-1 gene induction by lysophosphatidylcholine. Circulation Research 77, 530-535.
228. Öhrvall M, Sundlöf G & Vessby B (1996) Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. Journal of Internal Medicine 239, 111-117.
229. O'Meara NM, Lewis GF, Cabana VG, Iverius PH, Getz GS & Polonsky KS (1992) Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein response. Journal of Clinical Endocrinology and Metabolism 75, 465-471.
230. Oosthuizen W, Vorster HH, Jerling JC, Barnard HC, Smuts CM, Silvis N, Kruger A & Venter CS (1994) Both fish oil and olive oil lowered plasma fibrinogen in women with high baseline fibrinogen levels. Thrombosis and Haemostasis 72, 557-562.
231. Ordovas JM, Lopez-Miranda J, Mata P, Perez-Jiminez F, Lichtenstein AH & Schaefer EJ (1995) Gene-diet interaction in determining plasma lipid response to dietary intervention. Atherosclerosis 118, Suppl., S11-S27.
232. Ostlund-Lindqvist AM, Albanus L & Croon LB (1985) Effect of dietary fatty acids on microsomal enzymes and membranes. Lipids 20, 620-624.
233. Palinski W, Miller E & Witzum JL (1995) Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proceedings of the National Academy of Sciences USA 92, 821-825.
234. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D & Witztum JL (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proceedings of the National Academy of Sciences USA 86, 1372-1376.
235. Pan DA, Lillioja S, Milner MR, Kriketos AD, Baur LA, Bogardus C & Storlien LH (1995) Skeletal muscle membrane lipid composition is related to adiposity and insulin action. Journal of Clinical Investigation 96, 2802-2808.
236. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RC, Alvarez JO, Macaluso M, Acton RT, Copeland RB & Cousins AL (1994) Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. American Journal of Clinical Nutrition 59, 940-948.
237. Patsch JR (1987) Postprandial lipaemia. Baillière's Clinical Endocrinology and Metabolism 1, 551-580.
238. Pedersen A, Sandstrom B & Van Amelsvoort JMM (1997) The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. British Journal of Nutrition 78, 215-222.
239. Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J & Rosenberg IH (1996) Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 348, 1120-1124.
240. Pietinen P, Ascherio A, Korhonen P, Hartman AM, Willett WC, Albanes D & Virtamo J (1997) Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The alpha-tocopherol, beta-carotene cancer prevention study. American Journal of Epidemiology 145, 876-887.
241. Poston RN, Haskard DO, Coucher JR, Gall NP & Johnson-Tidey RR (1992) Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. American Journal of Pathology 140, 665-673.
242. Potts JL, Coppack SW, Fisher RM, Humphreys SM, Gibbons GF & Frayn KN (1995) Impaired postprandial clearance of triacylglycerol-rich lipoproteins in adipose tissue in obese subjects. American Journal of Physiology 268, E588-E594.
243. Pyörälä K (1979) Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2, 131-141.
244. Qureshi AA, Bradlow BA, Brace L, Manganello J, Peterson DM, Pearce BC, Wright JJ, Gapor A & Elson CE (1995) Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 30, 1171-1177.
245. Qureshi AA, Bradlow BA, Salser WA & Brace LD (1997) Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. Journal of Nutritional Biochemistry 8, 290-298.
246. Qureshi AA, Pearce BC, Nor RM, Gapor A, Peterson DM & Elson CE (1996) Dietary alpha-tocopherol attenuates the impact of gamma-tocotrienol on hepatic 3 hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. Journal of Nutrition 126, 389-394.
247. Rambjor GS, Walen AI, Windsor SL & Harris WS (1996) Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. Lipids 31, Suppl., S45-S49.
248. Rapaport SI & Rao LVM (1995) The tissue factor pathway: how it has become a "prima ballerina". Thrombosis and Haemostasis 74, 7-17.
249. Rasmussen O, Thomsen C, Ingerslev J & Hermansen K (1994) Decrease in von Willebrand factor levels after a high-monounsaturated-fat diet in non-insulin-dependent diabetic subjects. Metabolism 43, 1406-1409.
250. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
251. Reaven GM, Litthel H & Landsberg L (1996) Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympatho-adrenal system. New England Journal of Medicine 334, 374-381.
252. Richelsen B, Kristensen K & Pedersen SB (1996) Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins - a placebo controlled and double blind study. European Journal of Clinical Nutrition 50, 811-815.
253. Ridker PM, Cushman M, Stampfer MJ, Tracy RP & Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine 336, 973-979.
254. Ridker PM, Hennekens CH, Cerskus A & Stampfer MJ (1994) Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 90, 2236-2240.
255. Ridker PM & Vaughan DE (1995) Comment on NEJM. Hemostatic factors and the risk of myocardial infarction. New England Journal of Medicine 333, 389.
256. Riemersma RA (1995) n-3 Fatty acids and experimental arrhythmogenesis. In n-3 Fatty Acids: Prevention and Treatment in Vascular Disease, pp. 98-106 [SD Kristensen, EB Schmidt, R De Caterina and S Endres, editors]. Verona: Bi & Gi Publishers, and London: Springer-Verlag.
257. Riemersma RA, Sargent CA, Saman S, Rebergen SA & Abraham R (1988) Dietary fatty acids and ischaemic arrhythmias (letter). Lancet ii, 285-286.
258. Rimm EB, Klatsky A, Grobbee D & Stampfer MJ (1996) Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. British Medical Journal 312, 731-736.
259. Ripsin CM, Keenan JM, Jacobs DR Jr, Elmer JJ, Welch RR, van Horn L, Liu K, Turnbull WH, Thye FW, Kestin M, Hegsted M, Davidson DM, Davidson MH, Dugan LD, Demark-Wahnefried W & Beling S (1992) Oat products and lipid lowering. A meta-analysis. Journal of the American Medical Association 267, 3317-3325.
260. Robinson K, Gupta A, Dennis V, Arheart K, Chaudhary D, Green R, Vigo P, Mayer EL, Selhub J & Kutner M (1996) Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 94, 2743-2748.
261. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, Kottke MK, Savon SR, Selhub J & Nissen SE (1995) Hyper-homocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 92, 2825-2830.
262. Rocchini AP, Moorehead C, DeRemer S, Goodfriend TL & Ball DL (1990) Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension 15, 861-866.
263. Rodgers GM & Conn MT (1990) Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 74, 895-901.
264. Roselaar SE, Schonfeld G & Daugherty A (1995) Enhanced development of atherosclerosis in cholesterol fed rabbits by suppression of cell-mediated immunity. Journal of Clinical Investigation 96, 1389-1394.
265. Ross R (1995) Cell biology of atherosclerosis. Annual Reviews of Physiology 57, 791-804.
266. Roust RR & Jensen MD (1993) Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes 42, 1567-1573.
267. Rydholm H, Boström S, Eriksson E & Risberg B (1995) Complex intracellular signal transduction regulates tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type-1 (PAI-1) synthesis in cultured human umbilical vein endothelium. Scandinavian Journal of Laboratory and Clinical Investigation 55, 323-330.
268. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV & Bogardus C (1991) Racial differences in the relation between blood pressure and insulin resistance. New England Journal of Medicine 324, 733-739.
269. Salo MK, Vartiainen E, Puska P & Nikkari T (1985) Platelet aggregation in Finnish men and its relation to fatty acids in platelets, plasma and adipose tissue. Thrombosis and Haemostasis 54, 563-569.
270. Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE & Wu KK (1995) Association of fibrinolytic parameters with early atherosclerosis. The Aric Study. Circulation 91, 284-290.
271. Salonen JT, Seppänen K, Nyyssönen K, Korpela H, Kauhanen J, Kantola M, Tuomilehto J, Esterbauer H, Tatzber F & Salonen R (1995) Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation 91, 645-655.
272. Sanderson P, Yaqoob P & Calder PC (1995) Effects of dietary lipid manipulation upon rat spleen lymphocyte functions and the expression of lymphocyte surface molecules. Journal of Nutrition and Environmental Medicine 5, 119-132.
273. Santoli D, Phillips PD, Colt TL & Zurier RB (1990) Suppression of interleukin-2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Journal of Clinical Investigation 85, 424-432.
274. Sargent CA (1990) Dietary fat and ischaemic arrhythmias. PhD Thesis, University of Edinburgh.
275. Sargent C & Riemersma RA (1990) Polyunsaturated fatty acids and cardiac arrhythmias. Biochemical Society Transactions 18, 1077-1078.
276. Schienle HW, Seitz R, Rohner I, Lerch L, Krumpholz B, Krauss G, Fowler B, Baumgartner R, Willenbockel U & Egbring R (1994) Coagulation factors and markers of activation of coagulation in homocystinuria (HOCY): a study in two siblings. Blood Coagulation and Fibrinolysis 5, 873-878.
277. Schmitz C, Lindpaintner K, Verhoef P, Gaziano JM & Buring J (1996) Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study. Circulation 94, 1812-1814.
278. Schreck R, Albermann K & Baeuerle PA (1992) Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radical Research Communications 17, 221-237.
279. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ & Rosenberg IH (1995) Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis [see comments]. New England Journal of Medicine 332, 286-291.
280. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, O'Leary DH, Wolf PA, Rush D & Schaefer EJ (1996) Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population. Journal of Nutrition 126, 1258S-1265S.
281. Semafuko WEB, Rutledge CO & Dixon WR (1984) Alterations in myocardial alpha-adrenoceptor function by modification of dietary lipids. Federation Proceedings 43, 414.
282. Shahar E, Folsom AR, Wu KK, Dennis BH, Shimakawa T, Conlan MG, Davis CE & Williams OD (1993) Association of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The Atherosclerosis Risk in Communities (ARIC) Study. Arteriosclerosis and Thrombosis 13, 1205-1212.
283. Shaten BJ, Kuller LH & Neaton JD (1991) Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. MRFIT Research Group. Preventive Medicine 20, 655-659.
284. Shekelle RB, Missell LV, Paul O, Shyrock AM & Stamler J (1985) Fish consumption and mortality from coronary heart disease. New England Journal of Medicine 313, 820.
285. Silagy C & Neil A (1994) Garlic as a lipid lowering agent - a meta-analysis. Journal of the Royal College of Physicians, London 28, 39-45.
286. Silveira A, Karpe F, Blombäck M, Steiner G, Walldius G & Hamsten A (1994) Activation of coagulation factor VII during alimentary lipemia. Arteriosclerosis and Thrombosis 14, 60-69.
287. Simionescu N, Vasile E, Lupu, Popescu G & Simionescu M (1986) Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. American Journal of Pathology 123, 109-125.
288. Simon JA, Fong J, Bernert JT & Browner WS (1995) Serum fatty acids and the risk of stroke. Stroke 26, 778-782.
289. Simons LA, Balasubramaniam S, von Konigsmark M, Parfitt A, Simons J & Peters W (1995) On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis 113, 219-225.
290. Simonsen T, Vårtun A, Lyngmo V & Nordøy A (1987) Coronary heart disease, serum lipids and dietary fish in two communities in Northern Norway. Acta Medica Scandinavica 222, 237-245.
291. Simopoulos AP (1994) Is insulin resistance influenced by dietary linoleic acid and trans fatty acids? Free Radical Biology and Medicine 17, 367-372.
292. Skarfors ET, Lithell HO & Selinns I (1991) Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men. Journal of Hypertension 9, 217-223.
293. Smith P, Arnesen H & Holme I (1990) The effect of warfarin on mortality and reinfarction after myocardial infarction. New England Journal of Medicine 323, 147-152.
294. Sniderman A, Brown BG, Stewart BF & Cianflone K (1992) From familial combined hyperlipidaemia to hyperapo B: unravelling the overproduction of hepatic apolipoprotein B. Current Opinion in Lipidology 3, 137-142.
295. Spady DK, Woollett LA & Dietschy JM (1993) Regulation of plasma LDL cholesterol levels by dietary cholesterol and fatty acids. Annual Review of Nutrition 13, 355-381.
296. Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF & Robinson DR (1993) Dietary ω-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. Journal of Clinical Investigation 91, 651-660.
297. Springer TA (1990) Adhesion receptors of the immune system. Nature 346, 425-434.
298. Stabler SP, Allen RH, Savage DG & Lindenbaum J (1990) Clinical spectrum and diagnosis of cobalamin deficiency [see comments]. Blood 76, 871-881.
299. Stamler JS & Loscalzo J (1992) Endothelium-derived relaxing factor modulates the atherothrombogenic effects of homocysteine. Journal of Cardiovascular Pharmacology 20, Suppl. 12, S202-S204.
300. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D & Loscalzo J (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. Journal of Clinical Investigation 91, 308-318.
301. Stamler JS & Slivka A (1996) Biological chemistry of thiols in the vasculature and in vascular-related diseases. Nutrition Reviews 54, 1-30.
302. Stasse-Wolthuis M, Albers HF, van Jeveren JG, Wil-de Jong J, Hautvast JGAJ, Hermus RJ, Katan MB, Brydon WG & Eastwood MA (1980) Influence of dietary fiber from vegetables and fruits, bran or citrus pectin on serum lipids, fecal lipids, and colonic function. American Journal of Clinical Nutrition 33, 1745-1756.
303. Steering Committee of the Physicians' Health Study Research Group (1989) Final report on the aspirin component of the ongoing Physicians' Health Study. New England Journal of Medicine 321, 129-135.
304. Steinberg D, Parthasarathy S, Carew TE, Khoo JC & Witzum JL (1989) Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. New England Journal of Medicine 32, 915-923.
305. Steiner M, Glantz M & Lekos A (1995) Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks. American Journal of Clinical Nutrition 62, Suppl., 1381S-1384S.
306. Stemme S & Hansson GK (1994) Immune mechanisms in atherosclerosis. Coronary Artery Disease 5, 216-222.
307. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ & Brown MJ (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347, 781-786.
308. Stinson JC, Owens D, McBrinn S, Collins P, Johnson A & Tomkin GH (1993) The regulation of postprandial cellular cholesterol metabolism in type 2 diabetic and non-diabetic subjects. Diabetic Medicine 10, 420-426.
309. Storlien LH, Jenkins AB, Chisholm DJ, Pascal WS, Khouri S & Kraeger EW (1991) Influence of dietary fat composition on development of insulin resistance in rats: relationship to muscle triglyceride and omega 3 fatty acids in muscle phospholipids. Diabetes 40, 280-289.
310. Stout RW (1990) Insulin and atheroma. 20-Yr perspective. Diabetes Care 13, 631-654.
311. Stout RW & Vallance-Owen J (1969) Insulin and atheroma. Lancet i, 1078-1080.
312. Sundell IB & Rånby M (1993) Oat husk fiber decreases plasminogen activator inhibitor type 1 activity. Haemostasis 23, 45-50.
313. Tegelman R, Aberg T, Eklöf R, Pousette A, Carlstrom K & Berglund I (1996) Influence of a diet regimen on glucose homeostasis and serum lipid levels in male elite athletes. Metabolism 4, 435-441.
314. Temme EHM, Mensink RP & Hornstra G (1996) Comparison of the effect of diets enriched in lauric, palmitic, or oleic acids on serum lipids and lipoproteins in healthy women and men. American Journal of Clinical Nutrition 63, 897-903.
315. Thaulow E, Erikssen J, Sandvik L, Stormorken H & Cohn PF (1991) Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84, 613-617.
316. Thompson SG, Kienast J, Pyke SDM, Haverkate F & van de Loo JC (1995) Hemostatic factors and risk of myocardial infarction or sudden death in patients with angina pectoris. New England Journal of Medicine 332, 635-641.
317. Tonstad S, Refsum H, Sivertsen M, Christophersen B, Ose L & Ueland PM (1996) Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatric Research 40, 47-52.
318. Trials of Hypertension Collaborative Research Group (1992) The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention (Phase I). Journal of the American Medical Association 267, 1213-1220.
319. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R & Lee M (1994) Promotion of vascular muscle cell growth by homocysteine: a link to atherosclerosis. Proceedings of the National Academy of Sciences USA 91, 6369-6373.
320. Tsai JC, Wang H, Perrella MA, Yoshizumi M, Sibinga NE, Tan LC, Haber E, Chang TH, Schlegel R & Lee ME (1996) Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. Journal of Clinical Investigation 97, 146-153.
321. Tso P, Pinkston G, Klurfeld DM & Kritchevsky D (1984) The absorption and transport of dietary cholesterol in the presence of peanut oil or randomized peanut oil. Lipids 19, 11-16.
322. Tucker KL, Mahnken B, Wilson PW, Jacques P & Selhub J (1996) Folic acid fortification of the food supply. Potential benefits and risks for the elderly population. Journal of the American Medical Association 276, 1879-1885.
323. Turpeinen AM, Sauer R, Freese R, Pajari A-M & Mutanen M (1997) Platelets are similarly activated by both oleic acid and linoleic acid rich diets in healthy humans. Prostaglandins, Leukotrienes and Essential Fatty Acids 57, 228.
324. Turpeinen AM, Wubert J, Aro A, Lorenz R & Mutanen M (1998) Similar effects of diets rich in stearic acid or trans fatty acids on platelet function and endothelial prostacyclin production in humans. Arteriosclerosis, Thrombosis and Vascular Biology 18, 316-322.
325. Ubbink JB, Vermaak WJ, van der Merwe A & Becker PJ (1993) Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. American Journal of Clinical Nutrition 57, 47-53.
326. Ueda S, Elliott HL, Morton JJ & Connell JMC (1995) Enhanced pressor response to angiotensin I in normotensive men with a deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 25, 1266-1269.
327. Uhleman ER, Ten Pas JH, Lucky AW, Schulman JD, Mudd SH & Shulamn NR (1976) Platelet survival and morphology in homocysteinuria due to cystathionine synthase deficiency. New England Journal of Medicine 295, 1283-1286.
328. Van den Berg M, Boers GH, Franken DG, Blom HJ, Van Kamp GJ, Jakobs C, Rauwerda JA, Kluft C & Stehouwert CD (1995) Hyper-homocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. European Journal of Clinical Investigation 25, 176-181.
329. van de Vijver LPL, Kardinaal AFM, Grobbee DE, Princen HMG & van Poppel G (1997) Lipoprotein oxidation, antioxidants and cardiovascular risk. Epidemiologic evidence. Prostaglandins, Leukotrienes and Essential Fatty Acids 57, 479-487.
330. Vanhanen HT, Blomqvist S, Ehnholm C, Hyvonen M, Jauhiainen M, Torstila I & Miettinen TA (1993) Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanolester treatment. Journal of Lipid Research 34, 1535-1544.
331. Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH & Willett WC (1996) Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. American Journal of Epidemiology 143, 845-859.
332. Vollset SE, Heuch I & Bjelke E (1985) Fish consumption and mortality from coronary heart disease. New England Journal of Medicine 313, 820-821.
333. von Eckardstein A, Malinow MR, Upson B, Heinrich J, Schulte H, Schonfeld R, Kohler E & Assmann G (1994) Effects of age, lipoproteins and hemostatic parameters on the role of homocyst(e)ine as a cardiovascular risk factor in men. Arteriosclerosis and Thrombosis 14, 460-464.
334. Wahlqvist ML, Krivokuca-Bogetic Z, Lo CS, Hage B, Smith R & Lukito W (1992) Differential serum responses of tocopherols and tocotrienols during vitamin supplementation in hypercholesterolemic individuals without change in coronary risk factors. Nutrition Research 12, Suppl. 1, S181-S201.
335. Wang J, Dudman NP & Wilcken DE (1993) Effects of homocysteine and related compounds on prostacyclin production by cultured human vascular endothelial cells. Thrombosis and Haemostasis 70, 1047-1052.
336. Warshafsky S, Kamer RS & Sivak SL (1993) Effect of garlic on total serum cholesterol. A meta-analysis. Annals of Internal Medicine 119, 599-605.
337. Weber C, Erl W, Pietsch A, Danesch U & Weber PC (1995) Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cell stimulated by tumor necrosis factor-α. Arteriosclerosis, Thrombosis and Vascular Biology 15, 622-628.
338. Weidtmann A, Scheithe R, Hrboticky N, Pietsch A, Lorenz R & Siess W (1995) Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2. Arteriosclerosis, Thrombosis and Vascular Biology 15, 1131-1138.
339. Weinberger MH (1990) Clinical studies of the role of dietary sodium in blood pressure. In Hypertension: Pathophysiology, Diagnosis, and Management, pp. 1999-2010 [JH Laragh and BM Brenner, editors]. New York, NY: Raven Press.
340. Welborn TG, Breckenridge A, Rubinstein AH, Dollery CT & Fraser TR (1966) Serum-insulin in essential hypertension and peripheral vascular disease. Lancet 1, 1336-1337.
341. Westerband A, Mills JL, Marek JM, Heimark RL, Hunter GC & Williams SK (1997) Immunocytochemical determination of cell type and proliferation rate in human vein graft stenoses. Journal of Vascular Surgery 25, 64-73.
342. Weylandt KH, Kang JX & Leaf A (1996) Polyunsaturated fatty acids exert antiarrhythmic actions as free acids rather than in phospholipids. Lipids 31, 977-982.
343. Widhalm K, Stargel WW, Burns TS & Tschanz C (1994) Evaluation of clinical and biochemical parameters in children after consumption of microparticulated protein fat substitute (Simplesse). Journal of the American College of Nutrition 13, 392-396.
344. Williams RR, Hasstedt ST, Hunt SC, Wu LL, Hopkins PN, Berry TD, Stults BM, Barlow GK & Kuida H (1991) Genetic traits related to hypertension and electrolyte metabolism. Hypertension 17, Suppl. 1, I-69-I-73.
345. Wince LC, Hugman LE & Brenner GM (1984) Alteration of inotropic response in rat atria by dietary fat. Federation Proceedings 43, 2677.
346. World Hypertension League (1991) Alcohol and hypertension. Journal of Hypertension 5, 227-232.
347. Xu Q, Dietrich H, Steiner HJ, Gown AM, Mikuz G, Kaufmann SHE & Wick G (1992) Induction of atherosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arteriosclerosis and Thrombosis 12, 789-799.
348. Yaqoob P & Calder PC (1993) The effects of fatty acids on lymphocyte functions. International Journal of Biochemistry 25, 1705-1714.
349. Zhao B (1996) Role of lipoproteins in platelet activation. Blood Coagulation and Fibrinolysis 2, 270-273.
350. Zilversmit DB (1979) Atherogenesis: a postprandial phenomenon. Circulation 60, 473-485.
351. Zock PL, de Vries JH, de Fouw NJ & Katan MB (1995) Positional distribution of fatty acids in dietary triglycerides: effects on fasting blood lipoprotein concentrations in humans. American Journal of Clinical Nutrition 61, 48-55.
352. Zock PL, de Vries JHM & Katan MB (1994) Impact of myristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy women and men. Arteriosclerosis and Thrombosis 14, 567-575.